NCT00314210 Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. Status COMPLETED Phase PHASE3
NCT00313794 Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment Status COMPLETED Phase PHASE2
NCT00313313 A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas Status COMPLETED Phase PHASE3
NCT00313209 Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) Status COMPLETED Phase PHASE3
NCT00313183 A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00313170 A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg Status COMPLETED Phase PHASE2
NCT00312975 Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00309491 Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients Status COMPLETED Phase PHASE3
NCT00309478 Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients Status COMPLETED Phase PHASE3
NCT00308139 Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1) Status COMPLETED Phase PHASE3
NCT00306891 Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) Status COMPLETED Phase PHASE2
NCT00306540 Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder Status COMPLETED Phase PHASE3
NCT00306163 Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) Status COMPLETED Phase PHASE3
NCT00305487 Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417) Status COMPLETED Phase PHASE3
NCT00305461 Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101) Status COMPLETED Phase PHASE3
NCT00305448 A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg Status COMPLETED Phase PHASE2
NCT00303524 Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients Status COMPLETED Phase PHASE2